about
Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic PatientsA Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High CholesterolA Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High CholesterolA Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High CholesterolEffect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic LesionsAtorvastatin and LDL Profile in Non-Insulin Dependent Diabetes MellitusSafety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the BloodA Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast CancerDiagnosis and Therapy of Vulnerable Atherosclerotic PlaqueDoes Statin Therapy Reduce Sympathoexcitation in Hypertension?A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 DiabetesClinical Utility of Endothelial Dysfunction in PADA Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed DyslipidemiaEffect of a Fibrate and a Statin on Endothelial DysfunctionZoledronate With Atorvastatin in Renal Cell CarcinomaSafety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary DyslipidemiaAtorvastatin in Moderate Active Crohns DiseaseSafety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin StudiesStatin for Immunomudulation in SepsisStudy of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mgEzetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF PatientsDose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis CEffects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance ImagingA Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Medications With the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation MarkersComparison of the Combination of Fenofibrate and Simvastatin Versus AtorvastatinEffects of Hypolipemic Treatment on AdipokinesEffects of Atorvastatin on Endothelial Progenitor Cells After Coronary SurgeryUsing AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically IllThe Effect of Atorvastatin on Androgens, Glucose Metabolism and Inflammation in Polycystic Ovary Syndrome (PCOS) WomenEfficacy of Statins In Prevention of CINEffects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis PatientsStudies of Traditional Chinese Medicine Clinical Efficacy Evaluation IndexStatins Evaluation in Coronary Procedures and Revascularization TrialSalusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis PatientsA Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and AtorvastatinLow-dose Statins and Nutraceuticals in High-intensity Statin-intolerant PatientsSequential Therapy of Atorvastatin Improve Outcomes of ST-elevated Acute Myocardial Infarction
P4844
Q61906826-B9A2CB13-1B1F-4D36-9820-D8E271C4BC99Q61914431-4BE62C3A-8BFD-4A58-A853-FD5561591698Q61914457-CC4F9D67-69C3-44FD-AAE3-1DD5FE2E7A3EQ61914505-343F8AD3-5188-4517-8F56-FED920121003Q61914510-97C9A7A8-F405-4380-9340-FFA47F010497Q61914892-9774A630-FF59-4E2B-BA77-EA2125CC7A81Q61914914-046B6A83-36C6-4ECC-B646-E8CBB71CCFF3Q61915052-03802BA0-EE9A-4DF3-BDBF-C66E4C375AE0Q61915236-F3D7B90A-268A-4978-815C-CAF2F164127AQ61915296-68CB8C5D-A2B4-45A5-9AF9-5D8DDCCDC25EQ61917444-D35913A6-4688-4A00-A5D7-FC08CED325A7Q61917464-E21E92C4-97AC-49D5-AC15-FAC05436F734Q61917661-273AFD4A-A8C4-4819-BB79-67EB55FCBC07Q61917942-2692F8C3-76CF-4F25-B234-30CD9726DA44Q61917960-812BE13F-DE26-4241-9C87-3C82BC284F59Q61917971-E8B2F8A1-2A2F-4CF9-AE9C-32FB5CF7EDF9Q61918033-C2B41FD7-C416-4C48-A2D5-98082CB1BAC9Q61918278-9B514ECC-4E22-4ACA-9EAC-DC8D32D057EFQ61920707-233433D3-F446-4541-8AE4-33ECDFE88666Q61920841-D913C6B0-305C-4A97-9F3D-7418AE179935Q61920846-3BEB2C89-20DF-4F38-A0C2-D4931094083FQ61921313-0A64D05C-BB6D-4CF0-B03E-39BC2FF75ACCQ61922152-AA1DC08A-E07B-43C1-A8EF-FE6B2C589154Q61922535-D6ACD779-0D3E-4E86-AF57-F014C55561C4Q61923091-D13F9B17-310E-4466-93DD-B8543F620826Q61933691-F23388BC-147B-4F4B-A477-CB44FC5D8091Q61933886-2BB8A8C1-A582-489F-8994-DFB7E79562EAQ61934763-F74636BC-8743-4DD2-A51B-3AFF11467581Q61936240-ADFB5E10-084B-4A58-9C72-3B4D4A2D7808Q61936501-82F65E7D-E312-4B88-A227-3DD42847A3B4Q61938419-235F8EA9-B56C-461D-A543-3ADC9F646631Q61938604-16C58BD2-30F0-41F6-8795-9EF7BC54BE47Q61938619-6247E700-BAAE-47BA-A0F3-12F3A78B7AA8Q61957389-EEE58BAD-BC4C-4C45-B1F5-63C3C16096C3Q61957453-4976B73B-DDBE-4AAC-A806-7359BF5DD6C4Q61967725-30E28B4A-64FF-4349-A5A8-15871B999EF0Q61967803-EFE01BD1-0B5D-4BE8-B035-232E7E8F1AE7Q61967863-8D53B13C-AC55-4C48-B155-FD3EA9B4F217Q61969177-DE3050C6-8BA4-4CC6-8237-8BAFA57104F1Q61969536-15EBFAF4-40F8-4D14-BACB-E2CE72625386
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
atorvastatin calcium
@en
atorvastatinkalsium
@nn
sól wapniowa atorwastatyny
@pl
type
label
atorvastatin calcium
@en
atorvastatinkalsium
@nn
sól wapniowa atorwastatyny
@pl
altLabel
atorvastatin calcium anhydrous
@en
prefLabel
atorvastatin calcium
@en
atorvastatinkalsium
@nn
sól wapniowa atorwastatyny
@pl
P592
P661
P662
P683
P2017
CC(C)C1=C(C(=C(N1CC[C@H](C[C@H ...... CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]
P231
134523-03-8
P232
P233
CC(C)C1=C(C(=C(N1CCC(CC(CC(=O) ...... CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]
P234
1S/2C33H35FN2O5.Ca/c2*1-21(2)3 ...... /q;;+2/p-2/t2*26-,27-;/m11./s1
P235
FQCKMBLVYCEXJB-MNSAWQCASA-L
P2566
100.155.373
P274
C₆₆H₆₈CaF₂N₄O₁₀
P2840
P3117
DTXSID6044303
P3345
P592
CHEMBL393220
P652
C0GEJ5QCSO
P715
SALT000011
P7524
atorvastatin-calcium